e-learning
resources
Berlin 2008
Monday, 06.10.2008
Biomarkers and antibiotic treatment of exacerbations of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
E. Hagiwara, A. Sekine, T. Sato, T. Baba, T. Shinohara, T. Endo, Y. Sogo, R. Nishihira, S. Komatsu, Y. Matsumoto, T. Ogura, H. Takahashi (Yokohama, Japan)
Source:
Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Session:
Biomarkers and antibiotic treatment of exacerbations of COPD
Session type:
Oral Presentation
Number:
2755
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Hagiwara, A. Sekine, T. Sato, T. Baba, T. Shinohara, T. Endo, Y. Sogo, R. Nishihira, S. Komatsu, Y. Matsumoto, T. Ogura, H. Takahashi (Yokohama, Japan). Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease. Eur Respir J 2008; 32: Suppl. 52, 2755
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Clinical features of invasive pulmonary aspergillosis in critical ill patients with chronic respiratory disease
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: 782-800
Year: 2007
The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 138s
Year: 2001
Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Allergic/invasive pulmonary aspergillosis in CGD (chronic granulomatous disease) patients
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009
Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
PET‘s importance in chronic pulmonary aspergillosis
Source: Eur Respir J 2006; 28: Suppl. 50, 560s
Year: 2006
The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea
Source: Eur Respir J 2005; 26: Suppl. 49, 285s
Year: 2005
Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
Clinical relevance of respiratory pathogens in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept